Of the 86 percent of respondents currently using CBD, 88 percent said they are uncomfortable with synthetic CBD entering the market after the 31 March and even those who are comfortable with synthetic CBD agreed that labelling should be a requirement.

Only two percent of respondents reported that they preferred isolated ‘pure CBD’. Meanwhile, 62 percent prefer full spectrum (trace THC) and 28 percent prefer broad spectrum (reduced trace THC) products.